ST. Luke's Cornwall Hospital

ST. Luke's Cornwall Hospital was paid $26.16M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoST. LUKE'S CORNWALL HOSPITAL
NEWBURGH, NY 12550

33aNPI1003923434assigned 08/23/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$26.16M

24GClaims570,669

24DCodes billed245

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#50 of 231

Median peer was paid$561K

This provider vs. median47×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	21,134	$643K
2019	49,913	$1.86M
2020	77,091	$3.25M
2021	93,057	$4.27M
2022	109,409	$5.47M
2023	120,745	$5.92M
2024incomplete	99,320	$4.75M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	19%	29,289	27,187	$5.03M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	19%	30,152	27,412	$4.97M
99282	Emergency department visit for the evaluation and management, low to moderate severity	5.8%	8,794	8,196	$1.52M
96361	Intravenous infusion, hydration; each additional hour	4.9%	4,880	4,698	$1.29M
97602		4.6%	2,940	1,177	$1.22M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	4.4%	5,322	2,875	$1.14M
70450	Computed tomography, head or brain; without contrast material	3.8%	3,722	3,630	$1.00M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	3.7%	1,871	847	$964K
74177	Computed tomography, abdomen and pelvis; with contrast material	3.1%	2,978	2,927	$810K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.9%	4,752	4,606	$750K
80053	Comprehensive metabolic panel	2.3%	32,724	29,378	$604K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.0%	592	589	$535K

233 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	1.6%	1,472	$424K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.5%	1,859	$399K
36415	Collection of venous blood by venipuncture	1.4%	58,122	$367K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.1%	6,018	$289K
71275	Computed tomographic angiography, chest, with contrast material	1.1%	886	$276K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.0%	13,225	$262K
80048	Basic metabolic panel (calcium, ionized)	<1%	13,424	$255K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	38,957	$241K
G0378	Hospital observation service, per hour	<1%	1,664	$238K
12001		<1%	525	$237K
86850		<1%	5,957	$217K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,108	$188K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	231	$182K
86901		<1%	6,137	$163K
59025	Fetal non-stress test	<1%	1,661	$153K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	287	$150K
86900		<1%	6,130	$136K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,466	$118K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	740	$116K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,128	$95K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,386	$86K
83880		<1%	2,776	$83K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,092	$82K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,754	$67K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,246	$65K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,140	$64K
12011		<1%	129	$61K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,565	$56K
80061	Lipid panel	<1%	6,277	$51K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	407	$47K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	454	$46K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,271	$46K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,408	$45K
84443	Thyroid stimulating hormone (TSH)	<1%	5,288	$45K
29515		<1%	182	$44K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,828	$43K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,938	$38K
88342		<1%	412	$30K
76801		<1%	242	$30K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,084	$29K
90715		<1%	1,095	$29K
71046	Radiologic examination, chest; 2 views	<1%	3,216	$28K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	110	$27K
72125	Computed tomography, cervical spine; without contrast material	<1%	474	$26K
12002		<1%	56	$26K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,401	$25K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	90	$25K
97161		<1%	233	$24K
93970		<1%	39	$24K
93971		<1%	187	$22K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	314	$21K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	111	$18K
86703		<1%	1,407	$18K
84439		<1%	2,538	$17K
29125		<1%	76	$17K
82607		<1%	1,505	$16K
86618		<1%	1,180	$15K
76819	Fetal biophysical profile; without non-stress testing	<1%	291	$15K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	10,312	$15K
85027		<1%	3,952	$14K
82248		<1%	10,957	$13K
80076		<1%	1,119	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	982	$12K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	14,140	$12K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	4,894	$11K
88304		<1%	175	$10K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	12	$10K
82728		<1%	848	$9K
85610		<1%	4,698	$9K
86803		<1%	1,169	$9K
81003		<1%	13,312	$9K
82746		<1%	823	$9K
97116		<1%	235	$8K
76000		<1%	31	$8K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	42	$8K
J3490	Unclassified drugs	<1%	219	$8K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	12	$7K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	510	$6K
71045	Radiologic examination, chest; single view	<1%	6,588	$6K
83540		<1%	1,291	$6K
87040		<1%	1,434	$6K
83735		<1%	4,282	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	173	$5K
99157		<1%	3,658	$5K
97162		<1%	40	$5K
96375	Therapeutic injection; each additional sequential IV push	<1%	9,341	$5K
70486		<1%	45	$5K
83550		<1%	898	$5K
81025		<1%	1,531	$5K
82043		<1%	926	$4K
85730		<1%	2,947	$4K
84153		<1%	247	$4K
86140		<1%	1,717	$4K
76830	Ultrasound, transvaginal	<1%	53	$4K
82803		<1%	146	$3K
82550		<1%	3,090	$3K
87631		<1%	48	$3K
86592		<1%	1,167	$3K
72131		<1%	14	$3K
87641		<1%	133	$3K
84481		<1%	274	$3K
87088		<1%	3,323	$3K
87640		<1%	132	$3K
84703		<1%	4,975	$2K
84550		<1%	697	$2K
84484		<1%	5,951	$2K
84702		<1%	3,222	$2K
87070		<1%	985	$2K
80349		<1%	596	$2K
86617		<1%	146	$2K
80358		<1%	600	$2K
80353		<1%	484	$2K
76377		<1%	1,234	$2K
84480		<1%	406	$2K
83690		<1%	6,637	$2K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	12	$2K
84436		<1%	593	$2K
80323		<1%	295	$1K
80361		<1%	295	$1K
80348		<1%	295	$1K
80346		<1%	295	$1K
80356		<1%	294	$1K
80324		<1%	294	$1K
80365		<1%	295	$1K
80362		<1%	295	$1K
80367		<1%	294	$1K
80359		<1%	296	$1K
80345		<1%	295	$1K
0012A		<1%	70	$1K
99213	Doctor's office visit, returning patient (routine)	<1%	37	$1K
88341		<1%	13	$1K
97010		<1%	113	$1K
82947		<1%	1,692	$1K
86038		<1%	163	$1K
87186		<1%	484	$1K
86710		<1%	38	$1K
85651		<1%	426	$1K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,226	$1K
99156		<1%	3,878	$985.11
84100		<1%	1,283	$924.96
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,327	$868.20
87077		<1%	804	$852.19
85652		<1%	1,068	$811.85
0011A		<1%	68	$807.62
87252		<1%	238	$802.19
76857		<1%	44	$757.57
96376		<1%	968	$721.21
87522	Neg quan hep c or qual rna	<1%	15	$665.79
86480		<1%	13	$642.10
J8501	Aprepitant, oral, 5 mg	<1%	13	$610.64
83605		<1%	1,176	$560.27
87086	Culture, bacterial; quantitative colony count, urine	<1%	78	$552.04
C1769	Guide wire	<1%	82	$523.35
85378		<1%	939	$506.65
87184		<1%	818	$446.72
82150		<1%	1,836	$434.16
82553		<1%	496	$407.27
82805		<1%	14	$401.27
87081		<1%	1,661	$389.32
73030		<1%	90	$361.93
84403		<1%	15	$355.67
73630		<1%	321	$336.40
J8540	Dexamethasone, oral, 0.25 mg	<1%	251	$316.43
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,735	$291.65
74018		<1%	62	$281.38
81015		<1%	7,841	$263.50
73610		<1%	377	$263.20
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,324	$251.69
82384		<1%	240	$241.57
0002A		<1%	13	$237.88
J7050	Infusion, normal saline solution, 250 cc	<1%	1,705	$232.63
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,713	$230.03
C1889	Implantable/insertable device, not otherwise classified	<1%	25	$196.63
86431		<1%	40	$193.65
81001		<1%	1,308	$186.54
73110		<1%	79	$175.57
J0690	Injection, cefazolin sodium, 500 mg	<1%	749	$170.46
86706		<1%	29	$164.75
80320		<1%	719	$152.97
73560		<1%	191	$145.14
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	471	$113.12
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,134	$107.31
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,929	$101.85
80050	General health panel	<1%	211	$90.00
J2704	Injection, propofol, 10 mg	<1%	2,555	$89.08
87205		<1%	107	$76.55
73562		<1%	44	$69.49
85007		<1%	1,218	$68.30
82247		<1%	14	$64.08
87340		<1%	15	$61.65
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,837	$58.95
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	5,387	$52.38
86430		<1%	12	$48.44
73130		<1%	195	$47.33
82570		<1%	12	$46.63
83615		<1%	29	$44.23
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	130	$41.60
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	5,611	$41.20
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,844	$40.28
80364		<1%	236	$37.83
84156		<1%	12	$32.14
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,518	$32.01
J3535	Drug administered through a metered dose inhaler	<1%	561	$30.43
J3475	Injection, magnesium sulfate, per 500 mg	<1%	32	$27.80
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	885	$27.66
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	423	$21.90
84145		<1%	13	$21.78
80329		<1%	264	$16.04
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,553	$13.93
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	247	$12.52
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,940	$9.50
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	151	$8.49
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,077	$7.90
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	230	$6.81
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	59	$3.40
86308		<1%	33	$2.70
J2060	Injection, lorazepam, 2 mg	<1%	113	$1.44
J1644	Injection, heparin sodium, per 1000 units	<1%	109	$1.22
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	176	$0.81
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	716	$0.02
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	550	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	45	$0.00
87807		0%	29	$0.00
J8597	Antiemetic drug, oral, not otherwise specified	0%	15	$0.00
94760		0%	32	$0.00
99080		0%	2,835	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	52	$0.00
J7510	Prednisolone oral, per 5 mg	0%	68	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	13	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	42	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	16	$0.00
86771		0%	12	$0.00
88313		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBARTON, JILL (VICE PRESIDENT OF REVENUE CYCLE)